Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP).
about
The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel.A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib.Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.An overview of quinoline as a privileged scaffold in cancer drug discovery.ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.Molecular docking studies shows tivozanib and lapatinib as potential inhibitors of EML4-ALK translocation mediated fusion protein in non small cell lung cancer.2-Trifluoromethyl-2-Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)-Mediated Multidrug Resistance: Synthesis and Biological Evaluations.
P2860
Q35238509-C1FC7988-D536-4184-A016-0854CEE5C13AQ36121125-375C7CD5-3735-42B6-A0E1-326D8644C6C8Q36629578-DF492DE3-95B0-4631-9E58-4D8663B6FC26Q37637660-F8EA5874-3F6A-49C6-AF0A-DD2EEEB72311Q38718947-79180106-441F-4EE2-A541-FE2DEE8F5695Q39015818-0FA4D226-6E0C-425B-8F1C-724BA05DBF50Q39235281-F0AEB90B-D4A1-4A17-80DD-B35A0FE2FABAQ40852245-0353CB41-A754-4290-8E90-04A654E70312Q41712860-B8324EFF-92C7-4597-81BF-F254D214E905Q51170112-3C0E19F0-5E75-4088-950A-A67F246BD87E
P2860
Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tivozanib reverses multidrug r ...... lycoprotein) and ABCG2 (BCRP).
@en
Tivozanib reverses multidrug resistance mediated by ABCB1
@nl
type
label
Tivozanib reverses multidrug r ...... lycoprotein) and ABCG2 (BCRP).
@en
Tivozanib reverses multidrug resistance mediated by ABCB1
@nl
prefLabel
Tivozanib reverses multidrug r ...... lycoprotein) and ABCG2 (BCRP).
@en
Tivozanib reverses multidrug resistance mediated by ABCB1
@nl
P2093
P2860
P356
P1433
P1476
Tivozanib reverses multidrug r ...... lycoprotein) and ABCG2 (BCRP).
@en
P2093
Danwen Yang
Eduardo E Chufan
Rishil J Kathawala
Suresh V Ambudkar
Xiang Chen
Zhe-Sheng Chen
P2860
P304
P356
10.2217/FON.13.253
P407
P50
P577
2013-12-03T00:00:00Z